M&A Deal Summary |
|
|---|---|
| Date | 2019-10-02 |
| Target | Zaltanpharma Laboratories |
| Sector | Leisure |
| Buyer(s) | Riemser Arzneimittel AG |
| Sellers(s) | icon Group |
| Deal Type | Divestiture |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 1992 |
| Sector | Life Science |
| Revenue | 115M EUR (2014) |
Riemser Arzneimittel AG is a pharmaceutical company focuses on its activities is mainly due to the distribution and life cycle management of pharmaceuticals in therapeutic niche areas with high unmet medical needs. Riemser product range especially covers prescription drugs to treat serious diseases in the therapeutic areas of oncology, infectiology, neurology, in the cardiovascular field, in dermatology, rheumatology, tuberculosis treatment, for the treatment of obesity and primary axillary hyperhidrosis.
| DEAL STATS | # |
|---|---|
| Overall | 2 of 2 |
| Sector: Leisure M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: Spain M&A | 1 of 1 |
| Year: 2019 M&A | 1 of 1 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2012-04-26 |
anwerina AG
Kreuzlingen, Switzerland anwerina AG focuses on metabolic bone diseases, cartilage replacement therapy and the minimally-invasive surgical treatment of vertebral compression fractures. |
Buy | - |
icon Group is an international multi-channel marketing organization for the healthcare industry, including pharmaceutical laboratories, pharmacy chains, insurers, and governments, with innovative solutions specialized in the sector. icon Group is divided into different business units: Icon OCS, Icon Intelligence, Icon Talent, Icon Digital Solutions, Icon Tech & Apps, and I-konekt.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Leisure M&A | 1 of 1 |
| Type: Divestiture M&A Deals | 1 of 1 |
| Country: Spain M&A | 1 of 1 |
| Year: 2019 M&A | 1 of 1 |
